Literature DB >> 26491045

Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes.

Song Gao1, James A Carson2.   

Abstract

Mechanical stretch can activate muscle and myotube protein synthesis through mammalian target of rapamycin complex 1 (mTORC1) signaling. While it has been established that tumor-derived cachectic factors can induce myotube wasting, the effect of this catabolic environment on myotube mechanical signaling has not been determined. We investigated whether media containing cachectic factors derived from Lewis lung carcinoma (LLC) can regulate the stretch induction of myotube protein synthesis. C2C12 myotubes preincubated in control or LLC-derived media were chronically stretched. Protein synthesis regulation by anabolic and catabolic signaling was then examined. In the control condition, stretch increased mTORC1 activity and protein synthesis. The LLC treatment decreased basal mTORC1 activity and protein synthesis and attenuated the stretch induction of protein synthesis. LLC media increased STAT3 and AMP-activated protein kinase phosphorylation in myotubes, independent of stretch. Both stretch and LLC independently increased ERK1/2, p38, and NF-κB phosphorylation. In LLC-treated myotubes, the inhibition of ERK1/2 and p38 rescued the stretch induction of protein synthesis. Interestingly, either leukemia inhibitory factor or glycoprotein 130 antibody administration caused further inhibition of mTORC1 signaling and protein synthesis in stretched myotubes. AMP-activated protein kinase inhibition increased basal mTORC1 signaling activity and protein synthesis in LLC-treated myotubes, but did not restore the stretch induction of protein synthesis. These results demonstrate that LLC-derived cachectic factors can dissociate stretch-induced signaling from protein synthesis through ERK1/2 and p38 signaling, and that glycoprotein 130 signaling is associated with the basal stretch response in myotubes.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  AMPK; MAP kinase; cachexia; gp130; mTORC1

Mesh:

Substances:

Year:  2015        PMID: 26491045      PMCID: PMC4698448          DOI: 10.1152/ajpcell.00052.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  78 in total

Review 1.  Interleukin 6 as a key regulator of muscle mass during cachexia.

Authors:  James A Carson; Kristen A Baltgalvis
Journal:  Exerc Sport Sci Rev       Date:  2010-10       Impact factor: 6.230

2.  AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.

Authors:  Junyu Ning; David R Clemmons
Journal:  Mol Endocrinol       Date:  2010-04-02

Review 3.  The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis.

Authors:  Anthony M J Sanchez; Robin B Candau; Alfredo Csibi; Allan F Pagano; Audrey Raibon; Henri Bernardi
Journal:  Am J Physiol Cell Physiol       Date:  2012-06-13       Impact factor: 4.249

4.  Formation of sarcomeres in developing myotubes: role of mechanical stretch and contractile activation.

Authors:  P G De Deyne
Journal:  Am J Physiol Cell Physiol       Date:  2000-12       Impact factor: 4.249

Review 5.  Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome.

Authors:  Neil B Ruderman; Charlotte Keller; Ann-Marie Richard; Asish K Saha; Zhijun Luo; Xiaoqin Xiang; Mercedes Giralt; Vladimir B Ritov; Elizabeth V Menshikova; David E Kelley; Juan Hidalgo; Bente K Pedersen; Meghan Kelly
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

6.  NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release.

Authors:  Sergio Di Marco; Rachid Mazroui; Patrice Dallaire; Sridar Chittur; Scott A Tenenbaum; Danuta Radzioch; Andre Marette; Imed-Eddine Gallouzi
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

7.  Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling.

Authors:  Mitsunori Miyazaki; John J McCarthy; Mark J Fedele; Karyn A Esser
Journal:  J Physiol       Date:  2011-02-07       Impact factor: 5.182

8.  TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.

Authors:  Yi-Ping Li; Yuling Chen; Joseph John; Jennifer Moylan; Bingwen Jin; Douglas L Mann; Michael B Reid
Journal:  FASEB J       Date:  2005-03       Impact factor: 5.191

9.  Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.

Authors:  Fabio Penna; Domiziana Costamagna; Alessandro Fanzani; Gabriella Bonelli; Francesco M Baccino; Paola Costelli
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase.

Authors:  Victor Aguilar; Samira Alliouachene; Athanassia Sotiropoulos; Andrew Sobering; Yoni Athea; Fatima Djouadi; Sylvain Miraux; Eric Thiaudière; Marc Foretz; Benoit Viollet; Philippe Diolez; Jean Bastin; Paule Benit; Pierre Rustin; David Carling; Marco Sandri; Renée Ventura-Clapier; Mario Pende
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

View more
  21 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

2.  Electrical stimulation prevents doxorubicin-induced atrophy and mitochondrial loss in cultured myotubes.

Authors:  Blas A Guigni; Dennis K Fix; Joseph J Bivona; Bradley M Palmer; James A Carson; Michael J Toth
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-18       Impact factor: 4.249

3.  Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.

Authors:  Blas A Guigni; Jos van der Velden; C Matthew Kinsey; James A Carson; Michael J Toth
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-11-05       Impact factor: 4.310

Review 4.  Muscle alterations in the development and progression of cancer-induced muscle atrophy: a review.

Authors:  Megan E Rosa-Caldwell; Dennis K Fix; Tyrone A Washington; Nicholas P Greene
Journal:  J Appl Physiol (1985)       Date:  2019-11-14

5.  Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.

Authors:  Tomoya Fukawa; Benjamin Chua Yan-Jiang; Jason Chua Min-Wen; Elwin Tan Jun-Hao; Dan Huang; Chao-Nan Qian; Pauline Ong; Zhimei Li; Shuwen Chen; Shi Ya Mak; Wan Jun Lim; Hiro-Omi Kanayama; Rosmin Elsa Mohan; Ruiqi Rachel Wang; Jiunn Herng Lai; Clarinda Chua; Hock Soo Ong; Ker-Kan Tan; Ying Swan Ho; Iain Beehuat Tan; Bin Tean Teh; Ng Shyh-Chang
Journal:  Nat Med       Date:  2016-05-02       Impact factor: 53.440

6.  Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.

Authors:  Kyle R Bohnert; Yann S Gallot; Shuichi Sato; Guangyan Xiong; Sajedah M Hindi; Ashok Kumar
Journal:  FASEB J       Date:  2016-05-20       Impact factor: 5.191

7.  Systemic IL-6 regulation of eccentric contraction-induced muscle protein synthesis.

Authors:  Justin P Hardee; Dennis K Fix; Xuewen Wang; Edie C Goldsmith; Ho-Jin Koh; James A Carson
Journal:  Am J Physiol Cell Physiol       Date:  2018-04-11       Impact factor: 4.249

8.  Acute myotube protein synthesis regulation by IL-6-related cytokines.

Authors:  Song Gao; J Larry Durstine; Ho-Jin Koh; Wayne E Carver; Norma Frizzell; James A Carson
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-02       Impact factor: 4.249

9.  Effect of neuromuscular electrical stimulation on skeletal muscle size and function in patients with breast cancer receiving chemotherapy.

Authors:  Michael J Toth; Thomas B Voigt; Timothy W Tourville; Shannon M Prior; Blas A Guigni; Axel V Schlosberg; Isaac B Smith; Taylor J Forest; Peter A Kaufman; Marie E Wood; Hibba Rehman; Kim Dittus
Journal:  J Appl Physiol (1985)       Date:  2020-05-07

10.  Cancer-induced Cardiac Atrophy Adversely Affects Myocardial Redox State and Mitochondrial Oxidative Characteristics.

Authors:  David E Lee; Jacob L Brown; Megan E Rosa-Caldwell; Richard A Perry; Lemuel A Brown; Wesley S Haynie; Tyrone A Washington; Michael P Wiggs; Narasimhan Rajaram; Nicholas P Greene
Journal:  JCSM Rapid Commun       Date:  2020-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.